Rafarma Pharmaceuticals, Inc. (RAFA)
OTCMKTS
· Delayed Price · Currency is USD
0.0800
0.00 (0.00%)
Apr 25, 2025, 3:55 PM EDT
Rafarma Pharmaceuticals Statistics
Total Valuation
RAFA has a market cap or net worth of 6.71 million.
Market Cap | 6.71M |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
RAFA has 87.77 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 87.77M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 50.29 |
PB Ratio | 0.02 |
P/TBV Ratio | 0.02 |
P/FCF Ratio | n/a |
P/OCF Ratio | 268.22 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -12.19 |
Financial Efficiency
Return on equity (ROE) is -0.07% and return on invested capital (ROIC) is -0.04%.
Return on Equity (ROE) | -0.07% |
Return on Assets (ROA) | -0.04% |
Return on Invested Capital (ROIC) | -0.04% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.00 |
Inventory Turnover | 0.64 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.87% in the last 52 weeks. The beta is 1.12, so RAFA's price volatility has been higher than the market average.
Beta (5Y) | 1.12 |
52-Week Price Change | -20.87% |
50-Day Moving Average | 0.14 |
200-Day Moving Average | 0.09 |
Relative Strength Index (RSI) | 32.60 |
Average Volume (20 Days) | 25,542 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, RAFA had revenue of 133,333 and -117,223 in losses. Loss per share was -0.01.
Revenue | 133,333 |
Gross Profit | n/a |
Operating Income | -108,333 |
Pretax Income | -117,223 |
Net Income | -117,223 |
EBITDA | n/a |
EBIT | -108,333 |
Loss Per Share | -0.01 |
Balance Sheet
The company has 116,854 in cash and 240,036 in debt, giving a net cash position of -123,182 or -0.00 per share.
Cash & Cash Equivalents | 116,854 |
Total Debt | 240,036 |
Net Cash | -123,182 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | 329.75M |
Book Value Per Share | 40.49 |
Working Capital | 257,254 |
Cash Flow
Operating Cash Flow | 25,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -81.25% |
Pretax Margin | -87.92% |
Profit Margin | -87.92% |
EBITDA Margin | n/a |
EBIT Margin | -81.25% |
FCF Margin | n/a |
Dividends & Yields
RAFA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -1.75% |
FCF Yield | n/a |
Stock Splits
The last stock split was on November 20, 2012. It was a reverse split with a ratio of 0.1.
Last Split Date | Nov 20, 2012 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | 0 |
Piotroski F-Score | n/a |